News Headlines Article

New Diabetes Drug Faces a Critical Review Before an F.D.A. Advisory Panel
New York Times

New diabetes drugs are being developed that reduce blood sugar in a straightforward way — by causing it to be excreted in the urine.

On Tuesday, a committee that advises the Food and Drug Administration is to consider whether the first of those drugs can overcome safety concerns and reach the market.

The outcome of the F.D.A. review is far from certain.